South Africa jabs 2,000 children in test of Chinese vaccine

By MOGOMOTSI MAGOME
Associated Press

JOHANNESBURG (AP) — South Africa has started vaccinating some children and adolescents as part of the global Phase 3 clinical trials of China’s Sinovac Biotech COVID-19 vaccine for children aged between 6 months and 17 years. The global study will enroll 2,000 participants in South Africa and 12,000 others will be taking part in Kenya, the Philippines, Chile and Malaysia. The first children in South Africa were inoculated at the Sefako Makgatho Health Sciences University in the capital Pretoria to kick off the trials and the Sinovac company said others will get shots at 6 different sites across the country.